General Information of Drug (ID: DMIZWM6)

Drug Name
US8669361, 105 Drug Info
Synonyms SCHEMBL2523114; CHEMBL3652622; QVHWRVHLJFUJKP-UHFFFAOYSA-N; BDBM119382; US8669361, 105; 5-amino-2-(2,6-difluorophenyl)-N-(1-methyl-5-(piperidin-4-ylmethylamino)-1H-pyrazol-4-yl)thiazole-4-carboxamide
Cross-matching ID
PubChem CID
53482278
TTD Drug ID
DMIZWM6

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug(s) Targeting PIM-3 protein kinase (PIM3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9682991, 23 DMGTIP6 N. A. N. A. Patented [2]
US8889696, Staurosporine DMSYUHK N. A. N. A. Patented [3]
US8829193, 3 DM5ZGK3 N. A. N. A. Patented [4]
BDBM50061601 DMQ4TUE N. A. N. A. Patented [5]
US9580418, Example 8 DMGH9B3 N. A. N. A. Patented [6]
BDBM50061608 DM3MRD9 N. A. N. A. Patented [5]
US8481586, 15 DMFEUMZ N. A. N. A. Patented [7]
US9434725, 315 DM316FB N. A. N. A. Patented [8]
BDBM50061612 DMM8IDC N. A. N. A. Patented [5]
US8669361, 102 DM4G3OC N. A. N. A. Patented [9]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
PIM-3 protein kinase (PIM3) TTCGOIN PIM3_HUMAN Inhibitor [1]

References

1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use. US8669361.
2 Tricyclic compounds for use as kinase inhibitors. US9682991.
3 Substituted pyrido[2,3-d]pyrimidin-7(8H)-ones and therapeutic uses thereof. US8889696.
4 PIM kinase inhibitors and methods of their use. US8829193.
5 Azole compounds as PIM inhibitors. US9321756.
6 Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors. US9580418.
7 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors. US8481586.
8 5-azaindazole compounds and methods of use. US9434725.
9 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use. US9573943.